At what point (obviously beyond breakeven in the future) do they...

At what point (obviously beyond breakeven in the future) do they consider a special dividend of revenue to shareholders? Be it from ongoing sales smashing targets or a lucrative partnership deal... If the share price continues to lag or underperform compared to the announcements and achievements being made, something like that would serve two purposes, lighting a fire under the ass of the share price, and rewarding holders who have remained.

I've been accumulating for over 4 years now with an average of roughly the same price as today, and I know that's not nearly as long as some of you here (not to mention most of you would have significantly more invested). But to see where they are as a company today compared to 2019, with no gain in share value, is a tad astounding, and no surprise an ongoing discussion point amongst ourselves.

Lamenting aside, considering the progression since 2019 just reinforces why I remain happy to hold. I have no doubt that a turning point is approaching. They got a massive upfront deal off what they considered their lowest value product, and as Bedger's ongoing diligence displays, is clearly loved by one of the biggest dental groups worldwide, as even after the upfront deal, they continue to push Striate as their preferred product in the space. Remplir is partnered for distribution in Australia, and in the next quarter or two we will get updates on the regulatory study and what those results mean for Remplir's US market entry. Both products are already seeing big quarter on quarter growth in sales, and I bet what we've seen so far is nothing compared to what's coming based on the activity of our distributors. What else does the market need?!